nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.309	1	CbGbCtD
Bromocriptine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0243	0.0869	CbGeAlD
Bromocriptine—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0209	0.0574	CcSEcCtD
Bromocriptine—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0474	CcSEcCtD
Bromocriptine—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0132	0.0471	CbGeAlD
Bromocriptine—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0128	0.0456	CbGeAlD
Bromocriptine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0337	CcSEcCtD
Bromocriptine—Methysergide—SIGMAR1—amyotrophic lateral sclerosis	0.0119	1	CrCbGaD
Bromocriptine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0301	CcSEcCtD
Bromocriptine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0289	CcSEcCtD
Bromocriptine—Mania—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0282	CcSEcCtD
Bromocriptine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0102	0.0363	CbGeAlD
Bromocriptine—HTR7—pons—amyotrophic lateral sclerosis	0.01	0.0359	CbGeAlD
Bromocriptine—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00974	0.0268	CcSEcCtD
Bromocriptine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00966	0.0265	CcSEcCtD
Bromocriptine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00868	0.0238	CcSEcCtD
Bromocriptine—DRD1—nerve—amyotrophic lateral sclerosis	0.00833	0.0298	CbGeAlD
Bromocriptine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0205	CcSEcCtD
Bromocriptine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00721	0.0198	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00686	0.0188	CcSEcCtD
Bromocriptine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00668	0.0239	CbGeAlD
Bromocriptine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00633	0.0226	CbGeAlD
Bromocriptine—HTR2A—pons—amyotrophic lateral sclerosis	0.00626	0.0224	CbGeAlD
Bromocriptine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00623	0.0171	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00597	0.0164	CcSEcCtD
Bromocriptine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0149	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0149	CcSEcCtD
Bromocriptine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00537	0.0148	CcSEcCtD
Bromocriptine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00534	0.0191	CbGeAlD
Bromocriptine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00529	0.0145	CcSEcCtD
Bromocriptine—HTR7—nerve—amyotrophic lateral sclerosis	0.00521	0.0186	CbGeAlD
Bromocriptine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00515	0.0141	CcSEcCtD
Bromocriptine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00509	0.014	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0136	CcSEcCtD
Bromocriptine—DRD2—nerve—amyotrophic lateral sclerosis	0.00492	0.0176	CbGeAlD
Bromocriptine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0049	0.0175	CbGeAlD
Bromocriptine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00468	0.0129	CcSEcCtD
Bromocriptine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00468	0.0129	CcSEcCtD
Bromocriptine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00458	0.0164	CbGeAlD
Bromocriptine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00449	0.0123	CcSEcCtD
Bromocriptine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0119	CcSEcCtD
Bromocriptine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00416	0.0149	CbGeAlD
Bromocriptine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0113	CcSEcCtD
Bromocriptine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0112	CcSEcCtD
Bromocriptine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00408	0.0146	CbGeAlD
Bromocriptine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0108	CcSEcCtD
Bromocriptine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.0039	0.0139	CbGeAlD
Bromocriptine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0105	CcSEcCtD
Bromocriptine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00376	0.0134	CbGeAlD
Bromocriptine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0103	CcSEcCtD
Bromocriptine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00373	0.0102	CcSEcCtD
Bromocriptine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00373	0.0102	CcSEcCtD
Bromocriptine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00369	0.0101	CcSEcCtD
Bromocriptine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00369	0.0132	CbGeAlD
Bromocriptine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0101	CcSEcCtD
Bromocriptine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00358	0.0128	CbGeAlD
Bromocriptine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00961	CcSEcCtD
Bromocriptine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00955	CcSEcCtD
Bromocriptine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00933	CcSEcCtD
Bromocriptine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00927	CcSEcCtD
Bromocriptine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00919	CcSEcCtD
Bromocriptine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00909	CcSEcCtD
Bromocriptine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00901	CcSEcCtD
Bromocriptine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00325	0.0116	CbGeAlD
Bromocriptine—Tension—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00879	CcSEcCtD
Bromocriptine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00877	CcSEcCtD
Bromocriptine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0087	CcSEcCtD
Bromocriptine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00861	CcSEcCtD
Bromocriptine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.003	0.00823	CcSEcCtD
Bromocriptine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00805	CcSEcCtD
Bromocriptine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00803	CcSEcCtD
Bromocriptine—HTR1B—brainstem—amyotrophic lateral sclerosis	0.0029	0.0104	CbGeAlD
Bromocriptine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00787	CcSEcCtD
Bromocriptine—DRD4—brain—amyotrophic lateral sclerosis	0.00285	0.0102	CbGeAlD
Bromocriptine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00776	CcSEcCtD
Bromocriptine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00773	CcSEcCtD
Bromocriptine—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00281	0.01	CbGeAlD
Bromocriptine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00278	0.00993	CbGeAlD
Bromocriptine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0076	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00757	CcSEcCtD
Bromocriptine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00746	CcSEcCtD
Bromocriptine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00737	CcSEcCtD
Bromocriptine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00731	CcSEcCtD
Bromocriptine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00726	CcSEcCtD
Bromocriptine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00719	CcSEcCtD
Bromocriptine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00262	0.00935	CbGeAlD
Bromocriptine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00717	CcSEcCtD
Bromocriptine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00713	CcSEcCtD
Bromocriptine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0071	CcSEcCtD
Bromocriptine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00697	CcSEcCtD
Bromocriptine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00252	0.009	CbGeAlD
Bromocriptine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00252	0.009	CbGeAlD
Bromocriptine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00683	CcSEcCtD
Bromocriptine—DRD5—nervous system—amyotrophic lateral sclerosis	0.00245	0.00876	CbGeAlD
Bromocriptine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00243	0.00869	CbGeAlD
Bromocriptine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00242	0.00866	CbGeAlD
Bromocriptine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00661	CcSEcCtD
Bromocriptine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00656	CcSEcCtD
Bromocriptine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00652	CcSEcCtD
Bromocriptine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0065	CcSEcCtD
Bromocriptine—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00236	0.00843	CbGeAlD
Bromocriptine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00643	CcSEcCtD
Bromocriptine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00234	0.00835	CbGeAlD
Bromocriptine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00635	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00631	CcSEcCtD
Bromocriptine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0063	CcSEcCtD
Bromocriptine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00625	CcSEcCtD
Bromocriptine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00223	0.00798	CbGeAlD
Bromocriptine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00602	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00598	CcSEcCtD
Bromocriptine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00216	0.0077	CbGeAlD
Bromocriptine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00581	CcSEcCtD
Bromocriptine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00211	0.00755	CbGeAlD
Bromocriptine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00578	CcSEcCtD
Bromocriptine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00578	CcSEcCtD
Bromocriptine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00201	0.00718	CbGeAlD
Bromocriptine—DRD3—brain—amyotrophic lateral sclerosis	0.002	0.00715	CbGeAlD
Bromocriptine—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00197	0.00702	CbGeAlD
Bromocriptine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00194	0.00692	CbGeAlD
Bromocriptine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00194	0.00691	CbGeAlD
Bromocriptine—HTR6—brain—amyotrophic lateral sclerosis	0.00193	0.00688	CbGeAlD
Bromocriptine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00524	CcSEcCtD
Bromocriptine—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00189	0.00676	CbGeAlD
Bromocriptine—DRD5—brain—amyotrophic lateral sclerosis	0.00187	0.0067	CbGeAlD
Bromocriptine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00187	0.00669	CbGeAlD
Bromocriptine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00182	0.005	CcSEcCtD
Bromocriptine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.0018	0.00644	CbGeAlD
Bromocriptine—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.0018	0.00644	CbGeAlD
Bromocriptine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00483	CcSEcCtD
Bromocriptine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00173	0.00617	CbGeAlD
Bromocriptine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00465	CcSEcCtD
Bromocriptine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00461	CcSEcCtD
Bromocriptine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0046	CcSEcCtD
Bromocriptine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00458	CcSEcCtD
Bromocriptine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00434	CcSEcCtD
Bromocriptine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00156	0.00557	CbGeAlD
Bromocriptine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00154	0.00549	CbGeAlD
Bromocriptine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00152	0.00543	CbGeAlD
Bromocriptine—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00152	0.00542	CbGeAlD
Bromocriptine—ADRA1D—brain—amyotrophic lateral sclerosis	0.0015	0.00537	CbGeAlD
Bromocriptine—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00147	0.00525	CbGeAlD
Bromocriptine—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00522	CbGeAlD
Bromocriptine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00146	0.0052	CbGeAlD
Bromocriptine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00145	0.00519	CbGeAlD
Bromocriptine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00143	0.00512	CbGeAlD
Bromocriptine—DRD1—brain—amyotrophic lateral sclerosis	0.00143	0.00512	CbGeAlD
Bromocriptine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00143	0.0051	CbGeAlD
Bromocriptine—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00506	CbGeAlD
Bromocriptine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.0014	0.00501	CbGeAlD
Bromocriptine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00139	0.00498	CbGeAlD
Bromocriptine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00139	0.00496	CbGeAlD
Bromocriptine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00138	0.00491	CbGeAlD
Bromocriptine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00137	0.00488	CbGeAlD
Bromocriptine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00132	0.0047	CbGeAlD
Bromocriptine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00128	0.00456	CbGeAlD
Bromocriptine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00123	0.00438	CbGeAlD
Bromocriptine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00118	0.00421	CbGeAlD
Bromocriptine—HTR7—nervous system—amyotrophic lateral sclerosis	0.00117	0.00418	CbGeAlD
Bromocriptine—HTR1B—brain—amyotrophic lateral sclerosis	0.00116	0.00415	CbGeAlD
Bromocriptine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00115	0.00412	CbGeAlD
Bromocriptine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00114	0.00408	CbGeAlD
Bromocriptine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00113	0.00403	CbGeAlD
Bromocriptine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00113	0.00403	CbGeAlD
Bromocriptine—HTR1D—brain—amyotrophic lateral sclerosis	0.00112	0.00401	CbGeAlD
Bromocriptine—HTR2C—brain—amyotrophic lateral sclerosis	0.00111	0.00397	CbGeAlD
Bromocriptine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00111	0.00395	CbGeAlD
Bromocriptine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.0011	0.00394	CbGeAlD
Bromocriptine—ADRB1—brain—amyotrophic lateral sclerosis	0.00109	0.0039	CbGeAlD
Bromocriptine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00109	0.00388	CbGeAlD
Bromocriptine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00108	0.00384	CbGeAlD
Bromocriptine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00381	CbGeAlD
Bromocriptine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00106	0.0038	CbGeAlD
Bromocriptine—HTR2B—brain—amyotrophic lateral sclerosis	0.00105	0.00373	CbGeAlD
Bromocriptine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00104	0.00372	CbGeAlD
Bromocriptine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00104	0.0037	CbGeAlD
Bromocriptine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00102	0.00364	CbGeAlD
Bromocriptine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00101	0.00362	CbGeAlD
Bromocriptine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000996	0.00356	CbGeAlD
Bromocriptine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000972	0.00347	CbGeAlD
Bromocriptine—HTR1A—brain—amyotrophic lateral sclerosis	0.000936	0.00335	CbGeAlD
Bromocriptine—HTR7—brain—amyotrophic lateral sclerosis	0.000895	0.0032	CbGeAlD
Bromocriptine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000866	0.0031	CbGeAlD
Bromocriptine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000863	0.00308	CbGeAlD
Bromocriptine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000859	0.00307	CbGeAlD
Bromocriptine—DRD2—brain—amyotrophic lateral sclerosis	0.000846	0.00302	CbGeAlD
Bromocriptine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000827	0.00295	CbGeAlD
Bromocriptine—ADRA2C—brain—amyotrophic lateral sclerosis	0.000823	0.00294	CbGeAlD
Bromocriptine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000808	0.00289	CbGeAlD
Bromocriptine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00073	0.00261	CbGeAlD
Bromocriptine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000703	0.00251	CbGeAlD
Bromocriptine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000687	0.00245	CbGeAlD
Bromocriptine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000676	0.00241	CbGeAlD
Bromocriptine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000656	0.00234	CbGeAlD
Bromocriptine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000651	0.00232	CbGeAlD
Bromocriptine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000637	0.00227	CbGeAlD
Bromocriptine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000568	0.00203	CbGeAlD
Bromocriptine—HTR2A—brain—amyotrophic lateral sclerosis	0.000558	0.00199	CbGeAlD
Bromocriptine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000478	0.00171	CbGeAlD
Bromocriptine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000461	0.00165	CbGeAlD
Bromocriptine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00045	0.00161	CbGeAlD
Bromocriptine—ABCB1—brain—amyotrophic lateral sclerosis	0.000366	0.00131	CbGeAlD
Bromocriptine—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.48e-05	0.000429	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.48e-05	0.000429	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.48e-05	0.000429	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.48e-05	0.000428	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.47e-05	0.000425	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.45e-05	0.00042	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.45e-05	0.000419	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.45e-05	0.000418	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.44e-05	0.000417	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.44e-05	0.000416	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.43e-05	0.000413	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.42e-05	0.00041	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.41e-05	0.000408	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.41e-05	0.000406	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.41e-05	0.000406	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.000406	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.4e-05	0.000405	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.000403	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.0004	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.38e-05	0.000398	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.37e-05	0.000396	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.37e-05	0.000395	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.37e-05	0.000395	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.37e-05	0.000394	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.36e-05	0.000392	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.35e-05	0.000391	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.35e-05	0.00039	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.35e-05	0.000389	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.35e-05	0.000389	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000389	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.34e-05	0.000387	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.33e-05	0.000385	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.32e-05	0.000381	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.32e-05	0.000381	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.31e-05	0.00038	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.31e-05	0.000379	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.29e-05	0.000374	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.29e-05	0.000374	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.29e-05	0.000372	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.29e-05	0.000372	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.000371	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.27e-05	0.000367	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.27e-05	0.000367	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.27e-05	0.000367	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.25e-05	0.000362	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.25e-05	0.000361	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.24e-05	0.000359	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.24e-05	0.000359	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.24e-05	0.000358	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.23e-05	0.000356	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.23e-05	0.000356	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.22e-05	0.000354	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.22e-05	0.000354	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.22e-05	0.000353	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.00035	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.00035	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.21e-05	0.000349	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.2e-05	0.000348	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.19e-05	0.000345	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.19e-05	0.000345	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.19e-05	0.000345	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.19e-05	0.000343	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.17e-05	0.000339	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.16e-05	0.000334	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.16e-05	0.000334	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.16e-05	0.000334	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.15e-05	0.000332	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.15e-05	0.000332	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.15e-05	0.000331	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.14e-05	0.000329	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.14e-05	0.000328	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.13e-05	0.000328	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000325	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.12e-05	0.000323	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.11e-05	0.000322	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.11e-05	0.00032	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.11e-05	0.00032	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.1e-05	0.000318	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.09e-05	0.000316	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.09e-05	0.000316	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000314	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	0.000312	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.07e-05	0.00031	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.07e-05	0.00031	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.07e-05	0.000309	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.07e-05	0.000308	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.07e-05	0.000308	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.06e-05	0.000308	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.06e-05	0.000305	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.06e-05	0.000305	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.06e-05	0.000305	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.05e-05	0.000305	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000301	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000299	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.03e-05	0.000297	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.02e-05	0.000294	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000291	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.98e-06	0.000288	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	9.97e-06	0.000288	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.96e-06	0.000288	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.91e-06	0.000286	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	9.91e-06	0.000286	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.83e-06	0.000284	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.83e-06	0.000284	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.78e-06	0.000283	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.72e-06	0.000281	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.62e-06	0.000278	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.56e-06	0.000276	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.56e-06	0.000276	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.55e-06	0.000276	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.53e-06	0.000275	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.53e-06	0.000275	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.49e-06	0.000274	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.37e-06	0.000271	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.29e-06	0.000268	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.2e-06	0.000266	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.15e-06	0.000264	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.14e-06	0.000264	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.14e-06	0.000264	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.01e-06	0.00026	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.99e-06	0.00026	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.95e-06	0.000259	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.9e-06	0.000257	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.87e-06	0.000256	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.81e-06	0.000254	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.76e-06	0.000253	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.73e-06	0.000252	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.7e-06	0.000251	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.56e-06	0.000247	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.52e-06	0.000246	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	8.44e-06	0.000244	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.29e-06	0.000239	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.23e-06	0.000238	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.18e-06	0.000236	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.16e-06	0.000236	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.12e-06	0.000235	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.12e-06	0.000235	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	8.1e-06	0.000234	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.09e-06	0.000234	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.08e-06	0.000233	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	8.05e-06	0.000233	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.95e-06	0.00023	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.78e-06	0.000225	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.52e-06	0.000217	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.4e-06	0.000214	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.4e-06	0.000214	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.36e-06	0.000213	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.36e-06	0.000213	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.35e-06	0.000212	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.33e-06	0.000212	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.3e-06	0.000211	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.24e-06	0.000209	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.23e-06	0.000209	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.15e-06	0.000207	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.08e-06	0.000204	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.04e-06	0.000203	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.04e-06	0.000203	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.95e-06	0.000201	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.95e-06	0.000201	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.9e-06	0.000199	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.85e-06	0.000198	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.84e-06	0.000198	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.79e-06	0.000196	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.77e-06	0.000195	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.76e-06	0.000195	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.74e-06	0.000195	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.73e-06	0.000194	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.72e-06	0.000194	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.65e-06	0.000192	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.35e-06	0.000183	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.33e-06	0.000183	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.25e-06	0.000181	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.25e-06	0.000181	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.24e-06	0.00018	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.24e-06	0.00018	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.21e-06	0.00018	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.2e-06	0.000179	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.11e-06	0.000177	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.11e-06	0.000177	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.07e-06	0.000175	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.99e-06	0.000173	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.99e-06	0.000173	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.97e-06	0.000173	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.91e-06	0.000171	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.91e-06	0.000171	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.88e-06	0.00017	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.7e-06	0.000165	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.69e-06	0.000165	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.64e-06	0.000163	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.57e-06	0.000161	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.56e-06	0.000161	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.52e-06	0.000159	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.45e-06	0.000157	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.42e-06	0.000157	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.4e-06	0.000156	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.38e-06	0.000155	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.38e-06	0.000155	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.33e-06	0.000154	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.3e-06	0.000153	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.3e-06	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.27e-06	0.000152	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.19e-06	0.00015	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.15e-06	0.000149	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.12e-06	0.000148	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.98e-06	0.000144	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.9e-06	0.000142	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.83e-06	0.00014	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.79e-06	0.000138	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.78e-06	0.000138	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.72e-06	0.000136	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.71e-06	0.000136	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.71e-06	0.000136	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.68e-06	0.000135	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.62e-06	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.61e-06	0.000133	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.6e-06	0.000133	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.58e-06	0.000132	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.54e-06	0.000131	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.52e-06	0.000131	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.51e-06	0.00013	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.47e-06	0.000129	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.45e-06	0.000128	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.44e-06	0.000128	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.4e-06	0.000127	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.35e-06	0.000126	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.31e-06	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.28e-06	0.000124	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.17e-06	0.00012	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.06e-06	0.000117	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.06e-06	0.000117	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.05e-06	0.000117	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.01e-06	0.000116	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.01e-06	0.000116	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.99e-06	0.000115	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.91e-06	0.000113	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.81e-06	0.00011	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.65e-06	0.000106	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.63e-06	0.000105	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.62e-06	0.000105	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.49e-06	0.000101	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.47e-06	0.0001	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.43e-06	9.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.38e-06	9.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.33e-06	9.61e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.07e-06	8.86e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.04e-06	8.8e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.02e-06	8.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.95e-06	8.54e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.75e-06	7.93e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.35e-06	6.79e-05	CbGpPWpGaD
